Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-04

AUTHORS

Marc Evans, Barrie Chubb, Jens Gundgaard

ABSTRACT

INTRODUCTION: To estimate the cost-effectiveness of insulin degludec (IDeg) versus insulin glargine U100 (IGlar U100) and new-to-market basal insulin analogues in patients with diabetes in order to aid decision-making in a complex basal insulin market. METHODS: A simple, short-term model was used to evaluate the costs and effects of treatment with IDeg versus IGlar U100 over a 12-month period in patients with type 1 (T1DM) and type 2 diabetes (T2DM) from the perspective of the UK National Health Service. New-to-market basal insulin analogues were evaluated in scenario analyses. RESULTS: IDeg is dominant (more effective and less costly) versus IGlar U100 in patients with T1DM and patients with T2DM on a basal-only therapy regimen (T2DMBOT), and is cost-effective versus IGlar U100 in patients with T2DM on a basal-bolus regimen (T2DMB/B). In T1DM, lower costs are primarily driven by lower insulin costs, as a result of a lower daily dose of IDeg. In T2DMBOT, lower overall costs with IDeg are driven by lower costs of severe hypoglycaemic events due to the significant reduction in number of events with IDeg versus IGlar U100. Improvements in clinical outcomes in all three patient groups are a result of the reduced incidence of hypoglycaemic events. Sensitivity analyses demonstrate that the results are robust. Scenario analyses versus two new-to-market basal insulin analogues indicate that in patients with T1DM and T2DMBOT, IDeg is likely to be highly cost-effective versus IGlar biosimilar Abasaglar® and dominant versus IGlar U300 (Toujeo®). In T2DMB/B, IDeg is likely to be cost-effective versus both comparators, with incremental cost-effectiveness ratios (ICERs) below the accepted threshold. CONCLUSION: IDeg is a cost-effective alternative to IGlar U100 for patients with diabetes in the UK, and it also likely to be cost-effective versus two new-to-market basal insulin analogues. More... »

PAGES

275-291

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13300-017-0236-9

DOI

http://dx.doi.org/10.1007/s13300-017-0236-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1083845661

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28210866


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cardiff and Vale University Health Board", 
          "id": "https://www.grid.ac/institutes/grid.273109.e", 
          "name": [
            "University Hospital Llandough, Cardiff, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Evans", 
        "givenName": "Marc", 
        "id": "sg:person.01167546340.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167546340.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novo Nordisk (United Kingdom)", 
          "id": "https://www.grid.ac/institutes/grid.436696.8", 
          "name": [
            "Novo Nordisk Ltd, Gatwick, West Sussex, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chubb", 
        "givenName": "Barrie", 
        "id": "sg:person.01067301036.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067301036.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novo Nordisk (Denmark)", 
          "id": "https://www.grid.ac/institutes/grid.425956.9", 
          "name": [
            "Novo Nordisk A/S, Soborg, Copenhagen, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gundgaard", 
        "givenName": "Jens", 
        "id": "sg:person.0610060240.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610060240.74"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1111/dom.12250", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000463471"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.diabres.2004.02.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002585451"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3111/13696998.2013.852099", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002605190"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3111/13696998.2013.846262", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004788363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/030079904x1980", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005280433"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.28.11.2673", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006119385"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/030079906x115757", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006324797"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.diabres.2010.01.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009318119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-007-0599-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010943073", 
          "https://doi.org/10.1007/s00125-007-0599-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-007-0599-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010943073", 
          "https://doi.org/10.1007/s00125-007-0599-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-007-0599-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010943073", 
          "https://doi.org/10.1007/s00125-007-0599-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3111/13696990903336597", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011407413"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc14-0991", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011648550"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40262-014-0165-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012376480", 
          "https://doi.org/10.1007/s40262-014-0165-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40262-014-0165-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012376480", 
          "https://doi.org/10.1007/s40262-014-0165-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1477-7525-11-90", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013049175", 
          "https://doi.org/10.1186/1477-7525-11-90"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/heapol/czl018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014734015"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dme.12128", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020540884"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc14-2441", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021071301"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dom.12438", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022462912"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3111/13696998.2014.971160", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023138240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1463-1326.2012.01627.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024357147"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12325-013-0036-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025250023", 
          "https://doi.org/10.1007/s12325-013-0036-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-014-0076-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029423801", 
          "https://doi.org/10.1007/s13300-014-0076-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10198-010-0224-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029908098", 
          "https://doi.org/10.1007/s10198-010-0224-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3111/13696998.2014.975234", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030412243"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0806470", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034293538"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dom.12032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036450839"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.2012.03698.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038413706"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1463-1326.2012.01638.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040850913"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jval.2015.09.2118", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044795257"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1742-1241.2007.01316.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045068291"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa052187", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045615611"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dme.12878", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049306697"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.27.2.632", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050138266"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc15-0249", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070730045"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-04", 
    "datePublishedReg": "2017-04-01", 
    "description": "INTRODUCTION: To estimate the cost-effectiveness of insulin degludec (IDeg) versus insulin glargine U100 (IGlar U100) and new-to-market basal insulin analogues in patients with diabetes in order to aid decision-making in a complex basal insulin market.\nMETHODS: A simple, short-term model was used to evaluate the costs and effects of treatment with IDeg versus IGlar U100 over a 12-month period in patients with type 1 (T1DM) and type 2 diabetes (T2DM) from the perspective of the UK National Health Service. New-to-market basal insulin analogues were evaluated in scenario analyses.\nRESULTS: IDeg is dominant (more effective and less costly) versus IGlar U100 in patients with T1DM and patients with T2DM on a basal-only therapy regimen (T2DMBOT), and is cost-effective versus IGlar U100 in patients with T2DM on a basal-bolus regimen (T2DMB/B). In T1DM, lower costs are primarily driven by lower insulin costs, as a result of a lower daily dose of IDeg. In T2DMBOT, lower overall costs with IDeg are driven by lower costs of severe hypoglycaemic events due to the significant reduction in number of events with IDeg versus IGlar U100. Improvements in clinical outcomes in all three patient groups are a result of the reduced incidence of hypoglycaemic events. Sensitivity analyses demonstrate that the results are robust. Scenario analyses versus two new-to-market basal insulin analogues indicate that in patients with T1DM and T2DMBOT, IDeg is likely to be highly cost-effective versus IGlar biosimilar Abasaglar\u00ae and dominant versus IGlar U300 (Toujeo\u00ae). In T2DMB/B, IDeg is likely to be cost-effective versus both comparators, with incremental cost-effectiveness ratios (ICERs) below the accepted threshold.\nCONCLUSION: IDeg is a cost-effective alternative to IGlar U100 for patients with diabetes in the UK, and it also likely to be cost-effective versus two new-to-market basal insulin analogues.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s13300-017-0236-9", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1044057", 
        "issn": [
          "1869-6953", 
          "1869-6961"
        ], 
        "name": "Diabetes Therapy", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "name": "Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus", 
    "pagination": "275-291", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e53bb9db3391fd5abb2ebdae7ada30494cef106d078b10a0d6c0047105182e8b"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28210866"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101539025"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13300-017-0236-9"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1083845661"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13300-017-0236-9", 
      "https://app.dimensions.ai/details/publication/pub.1083845661"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000348_0000000348/records_54325_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs13300-017-0236-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13300-017-0236-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13300-017-0236-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13300-017-0236-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13300-017-0236-9'


 

This table displays all metadata directly associated to this object as RDF triples.

194 TRIPLES      21 PREDICATES      62 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13300-017-0236-9 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N5da5668e3665433682ad35fcb9061497
4 schema:citation sg:pub.10.1007/s00125-007-0599-y
5 sg:pub.10.1007/s10198-010-0224-8
6 sg:pub.10.1007/s12325-013-0036-1
7 sg:pub.10.1007/s13300-014-0076-9
8 sg:pub.10.1007/s40262-014-0165-y
9 sg:pub.10.1186/1477-7525-11-90
10 https://doi.org/10.1016/j.diabres.2004.02.008
11 https://doi.org/10.1016/j.diabres.2010.01.026
12 https://doi.org/10.1016/j.jval.2015.09.2118
13 https://doi.org/10.1056/nejmoa052187
14 https://doi.org/10.1056/nejmoa0806470
15 https://doi.org/10.1093/heapol/czl018
16 https://doi.org/10.1111/dme.12128
17 https://doi.org/10.1111/dme.12878
18 https://doi.org/10.1111/dom.12032
19 https://doi.org/10.1111/dom.12250
20 https://doi.org/10.1111/dom.12438
21 https://doi.org/10.1111/j.1463-1326.2012.01627.x
22 https://doi.org/10.1111/j.1463-1326.2012.01638.x
23 https://doi.org/10.1111/j.1464-5491.2012.03698.x
24 https://doi.org/10.1111/j.1742-1241.2007.01316.x
25 https://doi.org/10.1185/030079904x1980
26 https://doi.org/10.1185/030079906x115757
27 https://doi.org/10.2337/dc14-0991
28 https://doi.org/10.2337/dc14-2441
29 https://doi.org/10.2337/dc15-0249
30 https://doi.org/10.2337/diacare.27.2.632
31 https://doi.org/10.2337/diacare.28.11.2673
32 https://doi.org/10.3111/13696990903336597
33 https://doi.org/10.3111/13696998.2013.846262
34 https://doi.org/10.3111/13696998.2013.852099
35 https://doi.org/10.3111/13696998.2014.971160
36 https://doi.org/10.3111/13696998.2014.975234
37 schema:datePublished 2017-04
38 schema:datePublishedReg 2017-04-01
39 schema:description INTRODUCTION: To estimate the cost-effectiveness of insulin degludec (IDeg) versus insulin glargine U100 (IGlar U100) and new-to-market basal insulin analogues in patients with diabetes in order to aid decision-making in a complex basal insulin market. METHODS: A simple, short-term model was used to evaluate the costs and effects of treatment with IDeg versus IGlar U100 over a 12-month period in patients with type 1 (T1DM) and type 2 diabetes (T2DM) from the perspective of the UK National Health Service. New-to-market basal insulin analogues were evaluated in scenario analyses. RESULTS: IDeg is dominant (more effective and less costly) versus IGlar U100 in patients with T1DM and patients with T2DM on a basal-only therapy regimen (T2DMBOT), and is cost-effective versus IGlar U100 in patients with T2DM on a basal-bolus regimen (T2DMB/B). In T1DM, lower costs are primarily driven by lower insulin costs, as a result of a lower daily dose of IDeg. In T2DMBOT, lower overall costs with IDeg are driven by lower costs of severe hypoglycaemic events due to the significant reduction in number of events with IDeg versus IGlar U100. Improvements in clinical outcomes in all three patient groups are a result of the reduced incidence of hypoglycaemic events. Sensitivity analyses demonstrate that the results are robust. Scenario analyses versus two new-to-market basal insulin analogues indicate that in patients with T1DM and T2DMBOT, IDeg is likely to be highly cost-effective versus IGlar biosimilar Abasaglar® and dominant versus IGlar U300 (Toujeo®). In T2DMB/B, IDeg is likely to be cost-effective versus both comparators, with incremental cost-effectiveness ratios (ICERs) below the accepted threshold. CONCLUSION: IDeg is a cost-effective alternative to IGlar U100 for patients with diabetes in the UK, and it also likely to be cost-effective versus two new-to-market basal insulin analogues.
40 schema:genre research_article
41 schema:inLanguage en
42 schema:isAccessibleForFree true
43 schema:isPartOf N219af55e764f4401bb4b4067e496b02d
44 N7f43682ea87b459592147ff0006ba69a
45 sg:journal.1044057
46 schema:name Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus
47 schema:pagination 275-291
48 schema:productId N6011933ac8de4196bf038d9f6f3c2573
49 N79a81218850f4c56b3f3b52848e6d318
50 Naf2a82f55c1f4c1283149da610cd7547
51 Nec5492932ea2402588263498e6b24054
52 Nf36aae7c79864eebb531a7f088e933d4
53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083845661
54 https://doi.org/10.1007/s13300-017-0236-9
55 schema:sdDatePublished 2019-04-11T10:19
56 schema:sdLicense https://scigraph.springernature.com/explorer/license/
57 schema:sdPublisher N8c83d3ac3c73443389229cc72acf8f31
58 schema:url https://link.springer.com/10.1007%2Fs13300-017-0236-9
59 sgo:license sg:explorer/license/
60 sgo:sdDataset articles
61 rdf:type schema:ScholarlyArticle
62 N1cb506b0bbaf465e98309276d858713a rdf:first sg:person.01067301036.89
63 rdf:rest Nd411f1ef919f4b1d93c9eef16c9b045c
64 N219af55e764f4401bb4b4067e496b02d schema:issueNumber 2
65 rdf:type schema:PublicationIssue
66 N5da5668e3665433682ad35fcb9061497 rdf:first sg:person.01167546340.80
67 rdf:rest N1cb506b0bbaf465e98309276d858713a
68 N6011933ac8de4196bf038d9f6f3c2573 schema:name dimensions_id
69 schema:value pub.1083845661
70 rdf:type schema:PropertyValue
71 N79a81218850f4c56b3f3b52848e6d318 schema:name pubmed_id
72 schema:value 28210866
73 rdf:type schema:PropertyValue
74 N7f43682ea87b459592147ff0006ba69a schema:volumeNumber 8
75 rdf:type schema:PublicationVolume
76 N8c83d3ac3c73443389229cc72acf8f31 schema:name Springer Nature - SN SciGraph project
77 rdf:type schema:Organization
78 Naf2a82f55c1f4c1283149da610cd7547 schema:name nlm_unique_id
79 schema:value 101539025
80 rdf:type schema:PropertyValue
81 Nd411f1ef919f4b1d93c9eef16c9b045c rdf:first sg:person.0610060240.74
82 rdf:rest rdf:nil
83 Nec5492932ea2402588263498e6b24054 schema:name readcube_id
84 schema:value e53bb9db3391fd5abb2ebdae7ada30494cef106d078b10a0d6c0047105182e8b
85 rdf:type schema:PropertyValue
86 Nf36aae7c79864eebb531a7f088e933d4 schema:name doi
87 schema:value 10.1007/s13300-017-0236-9
88 rdf:type schema:PropertyValue
89 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
90 schema:name Medical and Health Sciences
91 rdf:type schema:DefinedTerm
92 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
93 schema:name Clinical Sciences
94 rdf:type schema:DefinedTerm
95 sg:journal.1044057 schema:issn 1869-6953
96 1869-6961
97 schema:name Diabetes Therapy
98 rdf:type schema:Periodical
99 sg:person.01067301036.89 schema:affiliation https://www.grid.ac/institutes/grid.436696.8
100 schema:familyName Chubb
101 schema:givenName Barrie
102 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067301036.89
103 rdf:type schema:Person
104 sg:person.01167546340.80 schema:affiliation https://www.grid.ac/institutes/grid.273109.e
105 schema:familyName Evans
106 schema:givenName Marc
107 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167546340.80
108 rdf:type schema:Person
109 sg:person.0610060240.74 schema:affiliation https://www.grid.ac/institutes/grid.425956.9
110 schema:familyName Gundgaard
111 schema:givenName Jens
112 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610060240.74
113 rdf:type schema:Person
114 sg:pub.10.1007/s00125-007-0599-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1010943073
115 https://doi.org/10.1007/s00125-007-0599-y
116 rdf:type schema:CreativeWork
117 sg:pub.10.1007/s10198-010-0224-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029908098
118 https://doi.org/10.1007/s10198-010-0224-8
119 rdf:type schema:CreativeWork
120 sg:pub.10.1007/s12325-013-0036-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025250023
121 https://doi.org/10.1007/s12325-013-0036-1
122 rdf:type schema:CreativeWork
123 sg:pub.10.1007/s13300-014-0076-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029423801
124 https://doi.org/10.1007/s13300-014-0076-9
125 rdf:type schema:CreativeWork
126 sg:pub.10.1007/s40262-014-0165-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1012376480
127 https://doi.org/10.1007/s40262-014-0165-y
128 rdf:type schema:CreativeWork
129 sg:pub.10.1186/1477-7525-11-90 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013049175
130 https://doi.org/10.1186/1477-7525-11-90
131 rdf:type schema:CreativeWork
132 https://doi.org/10.1016/j.diabres.2004.02.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002585451
133 rdf:type schema:CreativeWork
134 https://doi.org/10.1016/j.diabres.2010.01.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009318119
135 rdf:type schema:CreativeWork
136 https://doi.org/10.1016/j.jval.2015.09.2118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044795257
137 rdf:type schema:CreativeWork
138 https://doi.org/10.1056/nejmoa052187 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045615611
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1056/nejmoa0806470 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034293538
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1093/heapol/czl018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014734015
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1111/dme.12128 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020540884
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1111/dme.12878 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049306697
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1111/dom.12032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036450839
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1111/dom.12250 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000463471
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1111/dom.12438 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022462912
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1111/j.1463-1326.2012.01627.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1024357147
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1111/j.1463-1326.2012.01638.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1040850913
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1111/j.1464-5491.2012.03698.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1038413706
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1111/j.1742-1241.2007.01316.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1045068291
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1185/030079904x1980 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005280433
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1185/030079906x115757 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006324797
165 rdf:type schema:CreativeWork
166 https://doi.org/10.2337/dc14-0991 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011648550
167 rdf:type schema:CreativeWork
168 https://doi.org/10.2337/dc14-2441 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021071301
169 rdf:type schema:CreativeWork
170 https://doi.org/10.2337/dc15-0249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070730045
171 rdf:type schema:CreativeWork
172 https://doi.org/10.2337/diacare.27.2.632 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050138266
173 rdf:type schema:CreativeWork
174 https://doi.org/10.2337/diacare.28.11.2673 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006119385
175 rdf:type schema:CreativeWork
176 https://doi.org/10.3111/13696990903336597 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011407413
177 rdf:type schema:CreativeWork
178 https://doi.org/10.3111/13696998.2013.846262 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004788363
179 rdf:type schema:CreativeWork
180 https://doi.org/10.3111/13696998.2013.852099 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002605190
181 rdf:type schema:CreativeWork
182 https://doi.org/10.3111/13696998.2014.971160 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023138240
183 rdf:type schema:CreativeWork
184 https://doi.org/10.3111/13696998.2014.975234 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030412243
185 rdf:type schema:CreativeWork
186 https://www.grid.ac/institutes/grid.273109.e schema:alternateName Cardiff and Vale University Health Board
187 schema:name University Hospital Llandough, Cardiff, UK
188 rdf:type schema:Organization
189 https://www.grid.ac/institutes/grid.425956.9 schema:alternateName Novo Nordisk (Denmark)
190 schema:name Novo Nordisk A/S, Soborg, Copenhagen, Denmark
191 rdf:type schema:Organization
192 https://www.grid.ac/institutes/grid.436696.8 schema:alternateName Novo Nordisk (United Kingdom)
193 schema:name Novo Nordisk Ltd, Gatwick, West Sussex, UK
194 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...